{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:23:06Z","timestamp":1788520986478,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["2698\/ 4603\/5904"],"award-info":[{"award-number":["2698\/ 4603\/5904"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006013","name":"United Arab Emirates University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110071","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:52:29Z","timestamp":1780717949000},"page":"110071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["N-hydroxy-isocytidine: A direct-acting broad-Spectrum antiviral agent against respiratory viruses with potent activity against MERS-CoV"],"prefix":"10.1016","volume":"180","author":[{"given":"Abdalla E.A.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend M.","family":"Maaroof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana M.","family":"Abou Elfetouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikha S.","family":"Al Neyadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhy M.","family":"El-Adl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elsadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham A.I.","family":"Abou-Elkhair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110071_bb0005","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki AM","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2026.110071_bb0010","series-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Overview","author":"W.H. Organization","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110071_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle east respiratory syndrome","volume":"386","author":"Zumla A","year":"2015","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bioorg.2026.110071_bb0020","article-title":"Remdesivir, Sofosbuvir, Galidesivir, and tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study","volume":"253","author":"Ribavirin","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2026.110071_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.26264","article-title":"RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target","volume":"93","author":"Wang","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/v13040667","article-title":"Broad-spectrum antiviral strategies and nucleoside analogues","volume":"13","author":"Geraghty R.J","year":"2021","journal-title":"Viruses"},{"issue":"17(1)","key":"10.1016\/j.bioorg.2026.110071_bb0035","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1039\/D5MD00810G","article-title":"Prodrug strategies in developing antiviral nucleoside analogs","volume":"2","author":"Suresh R.R","year":"2026","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0040","doi-asserted-by":"crossref","first-page":"130110","DOI":"10.1016\/j.bmcl.2025.130110","article-title":"Nucleoside antiviral agents with atypical structures and new targets","volume":"119","author":"Xu H","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110071_bb0045","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/ijms26041481","article-title":"Potential broad-spectrum antiviral agents: a key. Arsenal against newly emerging and reemerging respiratory RNA viruses","volume":"26","author":"Luong QXT","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110071_bb0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman RT","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.bioorg.2026.110071_bb0055","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.abc1560","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin W","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110071_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coviro.2019.04.002","article-title":"Nucleoside analogues for the treatment of coronavirus infections","volume":"35","author":"Pruijssers AJ","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication \u2013 transcription complexes and their relevance for SARS-2 drug design","volume":"23","author":"Malone B","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0070","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi L","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110071_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000715","article-title":"A unifying structural and functional model of the coronavirus replication organelle: tracking down RNA synthesis","volume":"18","author":"Snijder EJ","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0080","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan TP","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.110071_bb0085","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"De Wit E","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110071_bb0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.coviro.2021.06.003","article-title":"Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19","volume":"50","author":"Painter GR","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0095","series-title":"Frontiers in Nucleosides and Nucleic Acids","first-page":"319","article-title":"Synthesis of Analogs of N4-hydroxycytidine with Potential Anti- HCV Activity","author":"Hollecker","year":"2004"},{"key":"10.1016\/j.bioorg.2026.110071_bb0100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1081\/NCN-200059224","article-title":"Synthesis and in vitro anti-HCV activity of \u03b2-D- and L-2\u2032-deoxy-2\u2032-fluororibonucleosides","volume":"24","author":"Shi","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.bioorg.2026.110071_bb0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/095632020601700203","article-title":"Inhibition of hepatitis C replicon RNA synthesis by beta-D-2\u2032-deoxy-2\u2032-fluoro-2\u2019-C-methylcytidine: a specific inhibitor of hepatitis C virus replication","volume":"17","author":"LJ","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bioorg.2026.110071_bb0110","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection","volume":"58","author":"J","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110071_bb0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/v10060283","article-title":"Saracatinib inhibits Middle East respiratory syndrome-coronavirus replication in vitro","volume":"10","author":"Shin J.S","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110071_bb0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.177.4050.705","article-title":"Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide","volume":"177","author":"Sidwell R.W","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2026.110071_bb0125","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-\u03b12b and ribavirin improves outcome in MERS-CoV\u2013infected rhesus","volume":"19","author":"D","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.110071_bb0130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.bioorg.2026.110071_bb0135","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"A","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110071_bb0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2018.04.004","article-title":"The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: early structural modifications to the nucleoside scaffold","volume":"154","author":"Seley-Radtke KL","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.bioorg.2026.110071_bb0145","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1039\/D0NJ04154H","article-title":"2-Hydroxyimino-6-aza-pyrimidine nucleosides: synthesis, DFT calculations, and antiviral evaluations","volume":"44","author":"RAI","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304139120","article-title":"2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses","volume":"120","author":"Uemura H","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.110071_bb0155","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1128\/JVI.77.19.10689-10694.2003","article-title":"Dynamics of subgenomic hepatitis C virus replicon RNA levels in Huh-7 cells after exposure to nucleoside antimetabolites","volume":"77","author":"Stuyver","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.bioorg.2026.110071_bb0160","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/ja909330m","article-title":"High fidelity of base pairing by 2-selenothymidine in DNA","volume":"132","author":"Hassan","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110071_bb0165","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1093\/nar\/gks010","article-title":"Novel RNA base air with higher specificity using single selenium atom","volume":"40","author":"H","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bioorg.2026.110071_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1021\/mp034019v","article-title":"Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug","volume":"12","author":"Tobias SC","year":"2004","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2026.110071_bb0175","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1021\/jm070269u","article-title":"Synthesis and biological activity of a gemcitabine phosphoramidate prodrug","volume":"50","author":"W","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0180","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-D-2\u2032-deoxy-2\u2032-\u03b1-fluoro-2\u2032-\u03b2-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"MJ","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0185","first-page":"1","article-title":"Synthesis of phosphoramidate prodrugs: ProTide approach","author":"Serpi M","year":"2013","journal-title":"Curr. Protoc. Nucleic Acid Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0190","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1021\/jm400201a","article-title":"Discovery of the first C -nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients","volume":"57","author":"A","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0195","doi-asserted-by":"crossref","first-page":"16897","DOI":"10.1074\/jbc.RA119.010214","article-title":"2\u2019-C-methylated nucleotides terminate virus RNA synthesis by preventing active site closure of the viral RNA-dependent RNA polymerase","volume":"294","author":"Boehr AK","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0200","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro","volume":"278","author":"Migliaccio G","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0205","first-page":"1","article-title":"Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus","volume":"9","author":"J","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.bioorg.2026.110071_bb0210","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1021\/jm040068f","article-title":"Structure-activity relationship of heterobase-modified 2\u2019-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication","volume":"47","author":"AB","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0215","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1074\/jbc.M210914200","article-title":"Inhibition of hepatitis C virus RNA replication by 2\u2032-modified nucleoside analogs","volume":"278","author":"Carroll SS","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0220","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/v2102169","article-title":"Inhibitors of the hepatitis C virus RNA-dependent RNA polymerase NS5B","volume":"2","author":"Powdrill MH","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2026.110071_bb0225","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ardp.19963290203","article-title":"Synthesis and antiviral activity of 5-substituted (2\u2019S)-2\u2032-deoxy-2\u2019-C-methylcytidines and -uridines","volume":"329","author":"S.S. Awano H, Miyashita T, Ashida N, Machida H, Kira T, Shigeta S, Matsuda A.","year":"1996","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bioorg.2026.110071_bb0230","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/jm00105a037","article-title":"Nucleosides and nucleotides. 94. Radical deoxygenation of tert-alcohols in 1-(2-C-alkylpentofuranosyl) pyrimidines: synthesis of (2\u2019S)-2\u2032-deoxy-2\u2019-C-methylcytidine, an antileukemic nucleoside","volume":"34","author":"Matsuda A","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0235","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/acs.joc.8b02194","article-title":"Synthesis of 2\u2032-Methyl-6-methoxyguanosine from the parent ribonucleoside guanosine","volume":"84","author":"C.K. Yuan C, Eastgate M.","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0240","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nrd2055","article-title":"Discovery and development of clofarabine: a nucleoside analogue for treating cancer","volume":"5","author":"Bonate PL","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.110071_bb0245","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1021\/jm00161a041","article-title":"9-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)guanine: a metabolically stable cytotoxic analogue of 2\u2032-deoxyguanosine","volume":"29","author":"Montgomery JA","year":"1986","journal-title":"J. Med. Chem."},{"issue":"977","key":"10.1016\/j.bioorg.2026.110071_bb0250","first-page":"509","article-title":"The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA)","volume":"40","author":"SS","year":"2026","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2026.110071_bb0255","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0040-4039(01)91909-4","article-title":"Nucleic acid related compounds. 13: 1-(2-Deoxy-2-\u03b2-D-erythro-pent-1-enofuranosyl)uracil. Synthesis of the first 1\u2032,2\u2032-unsaturated pyrimidine nucleoside, a furanoid N,O-ketene acetal","volume":"15","author":"MJ","year":"1974","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2026.110071_bb0260","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1248\/cpb.15.1498","article-title":"Some attempts on substitution of 2\u2032-position of uridine with thiol group","volume":"15","author":"Sekiya T","year":"1967","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bioorg.2026.110071_bb0265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jviromet.2017.03.012","article-title":"Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties","volume":"246","author":"Smee D.F","year":"2017","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bioorg.2026.110071_bb0270","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1134\/S1070363223060105","article-title":"Synthesis and Phosphonylation of S-methylthiouracil and its derivatives","volume":"93","author":"Skrylkova","year":"2023","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.bioorg.2026.110071_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1021\/acsmedchemlett.5b00402","article-title":"Synthesis and evaluation of 2,6-modified purine 2\u2032-C-methyl ribonucleosides as inhibitors of HCV replication","volume":"7","author":"Zhou","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.110071_bb0280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/15257770.2019.1646917","article-title":"Synthesis of 2\u2032-aminouridine derivatives as an organocatalyst for Diels-Alder reaction\u2020","volume":"39","author":"Wakamatsu","year":"2020","journal-title":"Nucleosides Nucleotides Nucleic Acids"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:40:32Z","timestamp":1787676032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"alternative-id":["S0045206826006073"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110071","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-hydroxy-isocytidine: A direct-acting broad-Spectrum antiviral agent against respiratory viruses with potent activity against MERS-CoV","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110071"}}